The Enterprise Value as of September 2024 (TTM) for YS Biopharma Co., Ltd. (YS) is 1.69B

According to YS Biopharma Co., Ltd.’s latest financial reports and current stock price. The company's current Enterprise Value is 1.69B. This represents a change of 125.91% compared to the average of 749.34M of the last 4 quarters.

YS Biopharma Co., Ltd. (YS) Historical Enterprise Value (quarterly & annually)

How has YS Enterprise Value performed in the past?

The mean historical Enterprise Value of YS Biopharma Co., Ltd. over the last ten years is 4.11B. The current 1.69B Enterprise Value has changed 4.02% with respect to the historical average. Over the past ten years (40 quarters), YS's Enterprise Value was at its highest in in the September 2022 quarter at 6.71B. The Enterprise Value was at its lowest in in the December 2022 quarter at 0.

YS Biopharma Co., Ltd. (YS) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of YS Biopharma Co., Ltd. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

YS Biopharma Co., Ltd. (YS) Average Enterprise Value

How has YS Enterprise Value performed in the past?

The current Enterprise Value of YS Biopharma Co., Ltd. (YS) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

YS Biopharma Co., Ltd. (YS) Enterprise Value vs. Peers

How is YS’s Enterprise Value compared to its peers?

YS Biopharma Co., Ltd.’s Enterprise Value is greater than Revelation Biosciences, Inc. (-10595486.00), greater than Cardio Diagnostics Holdings, Inc. (6.05M), greater than Biodexa Pharmaceuticals Plc (-5427625.85), greater than ZyVersa Therapeutics, Inc. (2.44M), greater than Sonnet BioTherapeutics Holdings, Inc. (1.12M), greater than Allarity Therapeutics, Inc. (-13133243.00), greater than Kiromic BioPharma, Inc. (11.97M), greater than Immix Biopharma, Inc. (27.90M), greater than CNS Pharmaceuticals, Inc. (3.51M), greater than eFFECTOR Therapeutics, Inc. (3.86M), greater than Navidea Biopharmaceuticals, Inc. (-2504975.00), greater than Virios Therapeutics, Inc. (2.43M), greater than Zura Bio Limited (40.51M), greater than Quoin Pharmaceuticals, Ltd. (-375166.00), greater than Virax Biolabs Group Limited (8.97M),

Build a custom stock screener for YS Biopharma Co., Ltd. (YS) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like YS Biopharma Co., Ltd. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

YS Biopharma Co., Ltd. (YS) and other stocks custom spreadsheet templates

The easiest way to analyze a company like YS Biopharma Co., Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.